For most patients, the established benefits of GLP-1 therapy in managing diabetes and obesity far outweigh theoretical concerns about pancreatic cancer that have not been supported by current evidence
While natural GLP-1 rarely causes problems, pharmaceutical GLP-1 agonists commonly cause gastrointestinal side effects including nausea, vomiting, diarrhea, and constipation, particularly during dose escalation
If you are breastfeeding, the recommendations are different
That's the difference between an informed enrollment and an expensive lesson
Individuals diagnosed with gastroparesis, bowel obstruction, NAION, pancreatitis, or other serious complications may pursue damages connected to hospitalization, surgery, long-term treatment, and ongoing medical care
Regul Pept (2014) 190-191:111